Mechanisms of Mutant LRRK2 Neurodegeneration. - Test2 - elhamkhani - TriplyDB

Mechanisms of Mutant LRRK2 Neurodegeneration.

Mechanisms of Mutant LRRK2 Neurodegeneration.

http://www.wikidata.org/entity/Q48239635

about

Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase.Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils.

P2860

Q46253834-332B59C6-7681-4A21-94E0-1CD53E98D248 Q47414771-D933FC66-2555-4572-AB2C-ACBF424075D6

P2860

Mechanisms of Mutant LRRK2 Neurodegeneration.

http://www.wikidata.org/entity/Q48239635

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Mechanisms of Mutant LRRK2 Neurodegeneration.

@en

Mechanisms of Mutant LRRK2 Neurodegeneration.

@nl

type

label

Mechanisms of Mutant LRRK2 Neurodegeneration.

@en

Mechanisms of Mutant LRRK2 Neurodegeneration.

@nl

prefLabel

Mechanisms of Mutant LRRK2 Neurodegeneration.

@en

Mechanisms of Mutant LRRK2 Neurodegeneration.

@nl

P1433

Q48239635-60679F58-AB62-40FB-8643-1576B5A78D22

P1476

Q48239635-33DC8E39-DCF0-4F0C-8FDC-63C39A8A500B

P2860

Q48239635-01883765-D90D-4191-B2F1-D2DFAB4F7820

Q48239635-0787A8DA-E10D-4660-8D27-71E9F95175D5

Q48239635-07B0D9D6-EC1B-4AF1-B87F-8A6C5A55F9F8

Q48239635-0D980E80-7DCC-4DE3-BC97-B37B86F70BBF

Q48239635-0E0CBB73-F8AE-4E58-903E-2A9F84296AAB

Q48239635-0ED38044-EE0F-45EF-A139-68C1E251B4FD

Q48239635-0EE8F470-6291-432D-AB15-528BF3467A45

Q48239635-16665548-4723-470B-8895-F9A9456E8D54

Q48239635-19370EC3-00D9-4830-9E40-CEB631908767

Q48239635-20FED93B-B965-47B1-9530-482903194495

P304

Q48239635-3A09D796-EA0E-4B66-9851-E4E24483E55E

P31

Q48239635-657BFD7C-DAB6-446A-A1B2-27106A1A911A

P356

Q48239635-1C3D2ABA-82EA-4A0F-8480-ED37C985A35D

P478

Q48239635-B50C3561-DD75-4242-BF5F-FAD9DB224155

P50

Q48239635-A9BCA533-82B9-47E2-971D-1CD8B21DF294

P577

Q48239635-CB664B43-E39A-49A9-A4E7-A1878CC9558B

P698

Q48239635-5B2680CE-CDF2-49C5-9903-4DEE2C3F8C57

P356

978-3-319-49969-7_12

P1433

Advances in neurobiology

P1476

Mechanisms of Mutant LRRK2 Neurodegeneration.

@en

P2860

Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2.

GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1

alpha-Synuclein and neuronal cell death

The Parkinson disease-linked LRRK2 protein mutation I2020T stabilizes an active state conformation leading to increased kinase activity

Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression

Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease

MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2

Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation

Progressive degeneration of human neural stem cells caused by pathogenic LRRK2

LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1

P304

227-239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-3-319-49969-7_12

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28353287

http://www.w3.org/2001/XMLSchema#string